ArticleEuropean urology2019

Re: Multicenter Prospective Phase II Trial of Neoadjuvant Dose-dense Gemcitabine Plus Cisplatin in Patients with Muscle-invasive Bladder Cancer.

Charlotte S Voskuilen et al.PubMed ↗Publisher ↗

No numbers read from the abstract.